Aggressive cancer cells halted

June 10, 2016

Zebrafish-human communication shows that cancer cells lacking a signaling protein are less able to develop aggressive metastatic properties. This discovery has been made by Claudia Tulotta. PhD defence 14 June.

Cancer cells create favourable circumstances for themselves in the human body. They do this by manipulating the body's direct environment, like immune cells, so that they do not attack but rather assist cancer cells. Scientists want to know how this interaction between cancer and immune calls works. This knowledge may provide possible starting points for halting the development of cancer.

Tulotta studied this interaction not in the , but in zebrafish embryos. Zebrafish has been increasingly used as a model to study cancer biology and similarities between zebrafish and human immune system are present. Tulotta injected fluorescent human cancer cells into the blood circulation of transparent two-day-old zebrafish embryos, with fluorescent blood vessels and . This made it possible for her to track the development and spread of the cancer cells in the living organism, while simultaneously interacting with surrounding zebrafish cells.

She studied two specific proteins. One – CXCR4 – is a product of cancer cells that is found on the surface of the cell. It plays an important role in the movement of cancer cells in response to another , CXCL12. This second protein can be found in both zebrafish and humans. It is produced by organs where tumor metastases are formed.

Tulotta: 'I have shown that cancer cells that produce a lot of CXCR4 behave more aggressively than cells with less CXCR4, in the . Aggressive cells leave the bloodstream and penetrate local tissues, where they can multiply. You can see this as an early step in the formation of metastases.

Tulotta applied two different methods to block the function of CXCR4. First, a pharmacological method: using a recently discovered inhibitor that prevents the protein from doing its work. The second method was genetic: CXCR4 gene function was impaired resulting in no protein production. Using both approaches, the aggressive behavior of cancer cells was halted.

Tulotta also carried out tests on zebrafish embryos that do not produce the CXCL12 protein. The introduced as part of the experiment did not demonstrate aggressive behaviour in these fish. 'This finding suggests that human and zebrafish cells communicate with each other, making the zebrafish embryo model suitable to study tumor behavior and interaction with the surrounding microenvironment.'

Tulotta believes there are opportunities for testing new CXCR4 inhibitors as a possible cancer treatment. The research may also be applied to drug development for other forms of cancer. Inhibiting CXCR4 was also shown to prevent metastasis initiation of Ewing sarcoma, a very rare form of bone cancer, in zebrafish.

Explore further: Signalling protein plays different roles in breast cancer and normal cells

Related Stories

Signalling protein plays different roles in breast cancer and normal cells

June 20, 2014
A key step in developing effective cancer therapies is identifying differences between normal, healthy cells and cancer cells – these differences can then be exploited to specifically kill tumour cells.

Researcher discovers a protein that spreads cancer

April 13, 2016
Nils Halberg at the University of Bergen has identified a protein that makes it possible for cancer cells to spread.

Fighting cancer with the help of someone else's immune cells

May 19, 2016
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone ...

Zebrafish help decode link between calcium deficiency and colon cancer

December 13, 2013
A tiny, transparent fish embryo and a string of surprises led scientists to a deeper understanding of the perplexing link between low calcium and colon cancer.

What can we learn from zebrafish about human blood disorders?

May 6, 2016
Genetic regulation of the various types of blood cells in zebrafish and humans is highly similar, making it relatively easy and cost-effective to perform genetic, chemical, imaging and other molecular studies on this invaluable ...

Disrupting tumor cell 'microenvironment' suggests a new way to treat a prevalent childhood leukemia

June 8, 2015
Researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center are reporting a potentially important discovery in the battle against one of the most devastating forms of leukemia that accounts ...

Recommended for you

Study suggests colon cancer cells carry bacteria with them when they metastasize

November 24, 2017
(Medical Xpress)—A team of researchers working at Harvard University has found evidence that suggests a certain type of bacteria found in colon cancer tumors makes its way to tumors in other body parts by traveling with ...

Promising new treatment for rare pregnancy cancer leads to remission in patients

November 24, 2017
An immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments have failed.

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.